PMGC Holdings ELAB
NASDAQ ELAB
$4.61 -0.01 (-0.32%)
As of: Sep 10, 2026 · 11:52 AM EDT

PMGC Holdings (ELAB) Net Shares Issued and Repurchased (2022 - 2025)

PMGC Holdings' (ELAB) quarterly Net Shares Issued and Repurchased came in at $3.0 in Q4 2025, down 99.26% year-over-year from $407.0 in Q4 2024, and down 93.02% quarter-over-quarter from $43.0 in Q1 2025.

Analysis

PMGC Holdings (ELAB) Net Shares Issued and Repurchased (2022 - 2025) Analysis & Trends

PMGC Holdings has disclosed Net Shares Issued and Repurchased across 4 years of filings, most recently posting $3.0 for Q4 2025.

  • In Q4 2025, Net Shares Issued and Repurchased fell 99.26% year-over-year to $3.0; the TTM figure through Dec 2025 stood at $3.0 (down 99.26% YoY), while the FY2025 annual figure was $3.0, down 99.26% from the prior year.
  • Net Shares Issued and Repurchased came in at $3.0 for Q4 2025 at PMGC Holdings, down from $43.0 in the prior quarter.
  • In the past five years, Net Shares Issued and Repurchased ranged from a high of $412000.0 in Q4 2022 to a low of $3.0 in Q4 2025.
  • Average Net Shares Issued and Repurchased over 4 years is $101390.0, with a median of $40203.5 recorded in 2023.
  • Year-over-year, Net Shares Issued and Repurchased sank 99.96% in 2023 and jumped 143.71% in 2024.
  • Over 4 years, Net Shares Issued and Repurchased stood at $412000.0 in 2022, then slumped by 99.96% to $167.0 in 2023, then soared by 143.71% to $407.0 in 2024, then slumped by 99.26% to $3.0 in 2025.
  • Per Business Quant data, the three most recent Net Shares Issued and Repurchased figures were $3.0 in Q4 2025, $43.0 in Q1 2025, and $407.0 in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued and Repurchased (Qtr)
1 Amgen 207.09 Bn 193.10 Bn 7.24 Bn -
2 Gilead Sciences 179.68 Bn 176.50 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 131.39 Bn 123.54 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 81.79 Bn 73.79 Bn 3.93 Bn -
5 Argenx Se 61.15 Bn 55.97 Bn 1.37 Bn -
6 Moderna 53.35 Bn 48.21 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 33.40 Bn 30.10 Bn 992.69 Mn -
8 Biogen 31.66 Bn 30.38 Bn 1.96 Bn -
9 Roivant Sciences 29.14 Bn 29.14 Bn 1.16 Mn -
10 PMGC Holdings 2.25 Mn -16.55 Mn 385,691.00 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 3.00
Mar 31, 2025 43.00
Dec 31, 2024 407.00
Mar 31, 2024 92,500.00
Dec 31, 2023 167.00
Jun 30, 2023 80,000.00
Dec 31, 2022 412,000.00
Sep 30, 2022 226,000.00